Indirect induction of regulatory T cells accompanies immune responses during peptide vaccination of chronic lymphocytic leukaemia patients

Br J Haematol. 2016 Jul;174(1):155-7. doi: 10.1111/bjh.13657. Epub 2015 Aug 25.
No abstract available

Keywords: T regulatory cells; chronic lymphocytic leukaemia; interleukin 2; peptide vaccination; thalidomide.

Publication types

  • Clinical Trial, Phase I
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cancer Vaccines
  • Case-Control Studies
  • Female
  • Humans
  • Immunity, Cellular*
  • Interleukin-2 / pharmacology
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy
  • Male
  • Middle Aged
  • T-Lymphocytes, Cytotoxic / immunology
  • T-Lymphocytes, Regulatory / immunology*
  • Thalidomide / pharmacology
  • Vaccination
  • Vaccines, Subunit

Substances

  • Cancer Vaccines
  • IL2 protein, human
  • Interleukin-2
  • Vaccines, Subunit
  • Thalidomide